Clinical trials
Osteoarthritis trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 5 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amway (China) R&D Center | 2 |
| Peking University Third Hospital | 2 |
| Smith & Nephew Medical (Shanghai) Ltd | 2 |
| Smith & Nephew, Inc. | 2 |
| Xiangya Hospital of Central South University | 2 |
| Guangzhou First People's Hospital | 1 |
| Jia-kuo yu | 1 |
| Johnson & Johnson Medical (Suzhou) Ltd. | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Smith & Nephew Orthopaedics (Beijing) Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoarthritis | 19 |
| Arthritis, Rheumatoid | 4 |
| Osteoarthritis, Knee | 4 |
| Femoral Neck Fractures | 2 |
| Osteonecrosis | 2 |
| Pain | 2 |
| Sarcopenia | 2 |
| Developmental Dysplasia of the Hip | 1 |
| Femur Head Necrosis | 1 |
| Hip Dislocation | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.